What is Diagnos-Techs?
Established in 1987, Diagnos-Techs operates as a specialized clinical and research laboratory dedicated to providing high-precision diagnostic solutions. The company has carved out a distinct market position by pioneering saliva-based testing for cortisol, subsequently broadening its portfolio to encompass comprehensive panels for hormonal health, food sensitivities, and gastrointestinal diagnostics. By leveraging advanced laboratory technology and a team of scientific experts, Diagnos-Techs serves as a critical partner for healthcare providers who require reliable, rapid, and non-invasive data to inform patient treatment plans. Their focus on scientific rigor and service excellence has allowed them to maintain a competitive edge in the diagnostic services industry for over three decades.
How much funding has Diagnos-Techs raised?
Diagnos-Techs has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Diagnos-Techs
PPP
Public-Private Partnership
What's next for Diagnos-Techs?
Following this late-stage financing, Diagnos-Techs is well-positioned to scale its laboratory infrastructure and expand its diagnostic panel offerings. The strategic allocation of these funds will likely focus on enhancing throughput capabilities and integrating next-generation sequencing or advanced analytical platforms to maintain its leadership in the non-invasive testing market. As the healthcare industry shifts toward personalized medicine and preventative care, the company is poised to capitalize on the growing demand for accessible, patient-centric diagnostic tools. Future growth initiatives will likely prioritize the expansion of their provider network and the refinement of their digital reporting systems to ensure seamless integration with clinical workflows, thereby reinforcing their role as a cornerstone of modern diagnostic research.
See full Diagnos-Techs company page
